S. 2531 · In committee · Health

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

Sponsor: Angela D. Alsobrooks (D-MD)

What it does

• Authorize HHS to conduct or support research on early detection of and medical intervention for uterine fibroids.
• Direct HHS to formulate strategies to increase early detection of uterine fibroids based on research findings.
• Authorize HHS to provide grants to states for screenings and public awareness campaigns related to uterine fibroids.
• Authorize HHS to provide grants to states for research on disparities in pain management in uterine fibroid surgical treatment and other uterine health conditions.

Official summary

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 This bill authorizes grants to support early detection of and intervention for uterine fibroids. Uterine fibroids are tumors in the wall of the uterus that are usually benign but can cause painful and heavy menstrual bleeding and other symptoms. The bill requires the Department of Health and Human Services (HHS) to (1) conduct or support research on increasing early detection of and medical intervention for uterine fibroids, and (2) formulate strategies to increase early detection based on such research. Also, the bill authorizes HHS to provide grants to states to increase early detection of and intervention for uterine fibroids (e.g., screenings) and to carry out public awareness campaigns. Additionally, the bill authorizes HHS to provide grants to states for research relating to (1) disparities in pain management in uterine fibroid surgical treatment; or (2) uterine health conditions, as determined appropriate by HHS. HHS must report to Congress every two years on the activities funded by grants under the bill, including findings from the research conducted by states.

Latest action

Mar 19, 2026: Committee on Health, Education, Labor, and Pensions. Hearings held.

Committee: Senate Health, Education, Labor, and Pensions